Correspondence 0001493152-24-049741 from PALISADE BIO, INC. (PALI)
PALISADE BIO, INC.
Date: Dec. 12, 2024 · CIK: 0001357459 · Accession: 0001493152-24-049741
AI Filing Summary & Sentiment
File numbers found in text: 333-282883
Show Raw Text
CORRESP
1
filename1.htm
Ladenburg
Thalmann & Co. Inc.
640
Fifth Avenue, 4th Floor
New
York, New York 10019
December
12, 2024
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
Re:
Palisade Bio, Inc.
Registration Statement on Form S-1 (Registration
No. 333-282883)
Concurrence in Acceleration Request
Ladies
and Gentlemen:
Ladenburg
Thalmann & Co. Inc. (“Ladenburg”), as representative of the underwriters for the referenced offering, hereby concurs
in the request by Palisade Bio, Inc. that the effective date of the above-referenced registration statement be accelerated to 12:00 p.m.
(Eastern Time), or as soon as practicable thereafter, on December 12, 2024, pursuant to Rule 461 under the Securities Act. Ladenburg
affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
LADENBURG THALMANN & CO. INC.
By:
/s/ Nicholas
Stergis
Name:
Nicholas Stergis
Title:
Managing Director